Recent reports indicated that SHC1 was a key driver of breast cancer initiation, and the SHC1 adaptor simultaneously balanced Stat1 and Stat3 activity to promote breast cancer immune suppression (48, 49). The gene discussed is STAT3; the disease is breast carcinoma.